Translumina Therapeutics Ventures into the UAE Market
Translumina Therapeutics, a key player in the coronary stents sector, has recently announced an exciting expansion into the UAE market. Since its founding in 2011, Translumina has focused on delivering advanced medical devices that enhance heart health. The company has an impressive portfolio of coronary intervention devices and has gained proficiency in its manufacturing processes.
A Vision for Global Healthcare
In a recent statement, Gurmit Singh Chugh, the Co-Founder and Chairman of Translumina, shared his vision to elevate India's position within the global medical devices space. He highlighted the significance of innovative engineering from India in addressing global healthcare needs. This new presence in the UAE perfectly embodies this ambition. The launch aligns with the broader national initiative of 'Make in India, Make for the world.'
Enhancing Global Reach
Supporting this vision, Punita Sharma Arora, Co-Founder and Vice-Chairman, discussed how the company has maintained a solid foothold in international markets over the last five years. Establishing a presence in the UAE is the latest step in Translumina's growth strategy, which already includes strong bases in Europe and South Asia. The company has made substantial investments to amplify its footprint in Latin America and Southeast Asia, with the UAE move paving the way for a broader reach in the MENA region.
Innovative Product Development
Translumina's cutting-edge drug-eluting stent technologies owe much to a successful partnership with the respected German Heart Centre. This collaboration has produced state-of-the-art medical devices known for their decade-long safety and effectiveness record. The company is committed to ongoing innovation to meet the changing needs of patients around the world.
Recent Strategic Acquisitions
Recently, Translumina strengthened its capabilities by acquiring Blue Medical, a Dutch firm renowned for its expertise in drug-coated balloons, along with Lamed, a significant player in the vascular surgery field in Germany. These acquisitions will likely enhance Translumina's offerings and boost its global competitiveness.
Dedication to Accessible Healthcare
Translumina's Group CEO, Indranil Mukherjee, expressed excitement about the company's aim to solidify its presence in the strategic and innovative environment of the UAE. This move is expected to improve access to quality healthcare services while expanding its international reach.
Get in Touch
For more information, Dr. Nancy Chugh is available to assist with inquiries. You can reach her at drnancychugh@translumina.in.
Frequently Asked Questions
What does the UAE launch mean for Translumina?
The UAE launch allows Translumina to gain a foothold in a strategic market, boosting its global presence and improving access to high-quality healthcare products.
When was Translumina established?
Translumina was founded in 2011, specializing in the production of advanced coronary intervention devices.
What companies has Translumina recently acquired?
Recently, Translumina acquired Blue Medical, which specializes in drug-coated balloons, and Lamed, a well-regarded company in the vascular surgery sector in Germany, to enhance its product range.
Who are the key executives at Translumina?
The leadership team at Translumina includes Co-Founder and Chairman Gurmit Singh Chugh, Co-Founder and Vice-Chairman Punita Sharma Arora, and Group CEO Indranil Mukherjee.
What is Translumina's vision moving forward?
The company's future vision is to position India as a leading hub for medical devices, highlighting its focus on innovation and quality in healthcare solutions.
